As part of its continued engagement with the global pharmaceutical, nutraceutical, and fine‑chemical sectors, ZUVCHEM is preparing to participate in several key industry events throughout 2026. These meetings provide an opportunity to strengthen relationships, engage with our valued clients and suppliers, and explore new sourcing and distribution opportunities across human health and veterinary markets.

 

Below is an overview of the events ZUVCHEM anticipates attending this year:

DCAT Week, New York, USA

March 23–26, 2026
Meet us in New York during DCAT Week 2026
as we connect with partners and explore new opportunities

SupplySide East,  Secaucus, New Jersey, USA

April 14-15, 2026
ZUVCHEM plans to attend SupplySide East 2026 to connect
with dietary ingredient suppliers, formulation partners,
and regulatory professionals serving the U.S. supplement
and nutrition markets.

CPhI Americas (North America),  Philadelphia, USA

June 2–4, 2026
ZUVCHEM will participate in CPhI North America 2026 in
Philadelphia, focusing on API sourcing, supply‑chain partnerships,
and business development across the pharmaceutical
manufacturing ecosystem.

CPhI Shanghai, China

June 16–18, 2026
ZUVCHEM anticipates attending CPhI Shanghai 2026,
an important platform for Supplier engagement, GMP‑compliant
API sourcing, and strategic discussions with Asian
manufacturing partners.

CPhI Worldwide, Milan, Italy

October 6–8, 2026
ZUVCHEM also plans to attend CPhI Worldwide 2026
in Milan, engaging with global stakeholders in APIs,
intermediates, and regulatory compliance.
Strengthening Global Collaboration:  Attendance at these events reflects ZUVCHEM’s commitment to maintaining a strong global network of suppliers, contract manufacturers, and regulatory partners while supporting U.S. compounding pharmacies with reliable, compliant API supply.

 

For meeting requests during any 2026 event, contact:
support@zuvchem.com
(908) 505‑3020
Discover more
March 1, 2026 in Events

ZUVCHEM Announces 2026 Industry Event Attendance Plans

As part of its continued engagement with the global pharmaceutical, nutraceutical, and fine‑chemical sectors, ZUVCHEM is preparing to participate in several key industry events throughout 2026. These meetings provide an opportunity to…
Read More
March 1, 2026 in News

ZUVCHEM Expands U.S. Licensing Footprint Across Multiple State Boards of Pharmacy

ZUVCHEM continues to strengthen its nationwide pharmaceutical distribution capabilities with a growing portfolio of active state licenses, renewals, and advanced-stage regulatory applications across the United States. These approvals support ZUVCHEM’s expanding…
Read More
March 1, 2026 in News

ZUVCHEM Launches U.S. Distribution of Cholecalciferol (Vitamin D3) 40 MIU/g API

ZUVCHEM announces the availability of Pharmaceutical‑Grade Cholecalciferol (Vitamin D3) 40,000,000 IU/g powder for prescription compounding use. The API is manufactured by Taizhou Hisound Pharmaceutical Co., Ltd. Labeled and distributed by ZUVCHEM across multiple…
Read More
Discover all products